ESPE Abstracts (2014) 82 P-D-3-3-847

ESPE2014 Poster Category 3 Growth (2) (13 abstracts)

Multiple Endocrinopathies in a Case with H Syndrome due to a Novel slc29a3 Mutation

Gul Yesiltepe Mutlu a , Heves Kirmizibekmez a , Elif Ozsu b , Abraham Zlotogorski c & Sukru Hatun b


aDepartment of Pediatric Endocrinology, Zeynep Kamil Woman’s and Children’s Diseases Training and Research Hospital, Istanbul, Turkey; bDepartment of Pediatric Endocrinology and Diabetes, Kocaeli University, Medical School, Kocaeli, Turkey; cDepartment of Dermatology and the Center for Genetic Diseases of the Skin and Hair, Hadassah-Hebrew University Medical Center, Jerusalem, Israel


Background: H syndrome (OMIM #602783) is an autosomal recessive syndrome resulted from mutations in the SLC29A3 gene, encoding hENT3 protein. Characteristic findings are cutaneous hyperpigmentation, hypertrichosis, hepatosplenomegaly, hypogonadism, hyperglycemia/diabetes mellitus, cardiac anomalies, hallux valgus and short stature. Herein we report a girl with multiple endocrinopathies due to H syndrome.

Case: Ten year and 5 month old girl was referred because of short stature. Her height was 115 cm (−3.8 SDS), weight was 20 kg (−2.8 SDS). She had fixed flexion contractures of the fingers and toes, and bilateral hallux valgus. Cutaneous induration, hyperpigmentation and hypertrichosis was evident on the thighs and external genitalia. Her pubertal stage was 1 according to Tanner staging. Mutation analysis of the SLC29A3 gene revealed a homozygous mutation in exon 6. Her thyroid function tests and morning cortisol levels were normal. She had high anti-tissue-transaminase levels and small intestine biopsy revealed celiac disease. On the 10th month of gluten-free diet, her growth rate was still low despite negative serologic markers of celiac disease. IGF1 level was 7.4 ng/ml and the peak GH level was 3.4 ng/ml. Although fasting serum glucose level was normal initially, it increased to 116 mg/dl in the follow-up period. Oral glucose tolerance test revealed impaired glucose tolerance and anti-GAD level was found very high (>200 U/ml). At the age of 12 years and 2 month old she still had no breast development and her peak LH level was detected as 3.19 mIU/ml in GnRH stimulation test. Impaired glucose tolerance, GH deficiency and possible hypogonadotropic hypogonadism are the main endocrinopathies in this case.

Conclusion: Seventy-nine cases with H syndrome were reported so far and some of these are noted to have various endocrinopathies, however etiopathogenesis of endocrinopathies associated H syndrome has not been lightened, yet. To our knowledge, this is the first report emphasising endocrinopathies related H syndrome.

Volume 82

53rd Annual ESPE (ESPE 2014)

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.